Search Results - "Chemotherapy, Adjuvant/adverse effects"
-
1
Authors: et al.
Source: New England Journal of Medicine. 393:37-50
Subject Terms: Adult, Male, Antibodies, Monoclonal, Humanized / adverse effects, Antibodies, Monoclonal, Humanized / administration & dosage, Young Adult, Chemotherapy, Adjuvant / methods, B7-H1 Antigen / analysis, B7-H1 Antigen / antagonists & inhibitors, Humans, Neoadjuvant Therapy / adverse effects, Antineoplastic Agents, Immunological / administration & dosage, Antineoplastic Agents, Immunological / adverse effects, Aged, Aged, 80 and over, Head and Neck Neoplasms / mortality, Head and Neck Neoplasms / pathology, Squamous Cell Carcinoma of Head and Neck / pathology, Middle Aged, Head and Neck Neoplasms / drug therapy, Neoadjuvant Therapy / methods, Progression-Free Survival, Squamous Cell Carcinoma of Head and Neck / surgery, Intention to Treat Analysis, B7-H1 Antigen / metabolism, Treatment Outcome, Head and Neck Neoplasms / surgery, Squamous Cell Carcinoma of Head and Neck / drug therapy, Female, Chemotherapy, Adjuvant / adverse effects, Squamous Cell Carcinoma of Head and Neck / mortality
File Description: application/pdf
-
2
Authors: et al.
Source: Breast Cancer
Subject Terms: Quality of life, Cancer-related fatigue, Breast Neoplasms, Neoadjuvant chemotherapy, Neoadjuvant Therapy, 3. Good health, ddc, Breast cancer, Original Article, Cohort study, Medical and Health Sciences, Chemotherapy, Adjuvant, Antineoplastic Combined Chemotherapy Protocols, Quality of Life, Humans, Female [MeSH], Humans [MeSH], Prospective Studies [MeSH], Neoadjuvant Therapy/adverse effects [MeSH], Breast Neoplasms/psychology [MeSH], Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Quality of Life [MeSH], Chemotherapy, Adjuvant/adverse effects [MeSH], Female, Prospective Studies
File Description: application/pdf
-
3
Authors: et al.
Source: J Cancer Res Clin Oncol
Journal of Cancer Research and Clinical Oncology, Vol 151, Iss 1, Pp 1-13 (2024)Subject Terms: Male, Adult, Skin Neoplasms, Research, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Patient preferences, Patient Preference, Middle Aged, Patient Acceptance of Health Care, Adjuvant therapy, Melanoma/therapy [MeSH], Female [MeSH], Skin Neoplasms/psychology [MeSH], Melanoma, Qualitative interviews, Aged [MeSH], Adult [MeSH], Humans [MeSH], Patient Acceptance of Health Care/psychology [MeSH], Middle Aged [MeSH], Skin Neoplasms/drug therapy [MeSH], Melanoma/psychology [MeSH], Immunotherapy/adverse effects [MeSH], Immunotherapy/methods [MeSH], Qualitative Research [MeSH], Male [MeSH], Quality of Life [MeSH], Chemotherapy, Adjuvant/adverse effects [MeSH], Patient Preference/psychology [MeSH], Melanoma/drug therapy [MeSH], 03 medical and health sciences, 0302 clinical medicine, Chemotherapy, Adjuvant, Quality of Life, Humans, Female, Immunotherapy, RC254-282, Qualitative Research, Aged
-
4
Authors: et al.
Contributors: et al.
Source: Clinical Breast Cancer, 22, 5, pp. 439-454
Subject Terms: Cancer Research, Drug-Related Side Effects and Adverse Reactions, Persuasive Communication, Breast Neoplasms, Self-affirmation, Stereotype threat, 03 medical and health sciences, Chemotherapy, Adjuvant/adverse effects, Drug-Related Side Effects and Adverse Reactions/etiology, Breast cancer, Cognition, 0302 clinical medicine, Chemotherapy-related cognitive symptoms, Journal Article, Humans, 0501 psychology and cognitive sciences, Breast Neoplasms/psychology, Longitudinal Studies, Prospective Studies, First Language Acquisition, Nocebo, Research Support, Non-U.S. Gov't, 05 social sciences, Language & Communication, 3. Good health, Oncology, Chemotherapy, Adjuvant, Randomized Controlled Trial, Female
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/35491320
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/288838
https://doi.org/10.1016/j.clbc.2022.03.001
https://hdl.handle.net/11245.1/bb7bd8a9-91b2-47b5-871c-d550eb78e4d1
https://doi.org/10.1016/j.clbc.2022.03.001
https://dare.uva.nl/personal/pure/en/publications/the-effects -of-being-informed-about-chemotherapyrelated-cognitive-symptoms-with-and-without-selfaffirmation-on-perceived-cognitive-symptoms-of-breast-cancer-patients-a-randomized-prospective-longitudinal-study(bb7bd8a9-91b2-47b5-871c-d550eb78e4d1).html
https://dspace.library.uu.nl/handle/1874/447798
https://repository.ubn.ru.nl/handle/2066/288838
https://repository.ubn.ru.nl//bitstream/handle/2066/288838/288838.pdf -
5
Authors: et al.
Contributors: et al.
Source: Int J Cancer
Subject Terms: Oxaliplatin/toxicity, Cancer Research, Clinical Trials as Topic, 3. Good health, adjuvant chemotherapy, Oxaliplatin, 03 medical and health sciences, Chemotherapy, Adjuvant/adverse effects, 0302 clinical medicine, colon cancer, Colonic Neoplasms/drug therapy, Oncology, Chemotherapy, Adjuvant, Colonic Neoplasms, Practice Guidelines as Topic, Journal Article, cancer registry, Humans, guideline, Cancer Epidemiology, Aged, Neoplasm Staging
File Description: application/pdf
-
6
Authors: et al.
Source: World J Gastroenterol
Vindum, H H, Agnholt, J S, Nielsen, A W M, Nielsen, M B & Schmidt, H 2020, 'Severe steroid refractory gastritis induced by Nivolumab : A case report', World Journal of Gastroenterology, vol. 26, no. 16, pp. 1971-1978. https://doi.org/10.3748/wjg.v26.i16.1971, https://doi.org/10.3748/wjg.v26.i16.1971
Vindum, H H, Agnholt, J S, Nielsen, A W M, Nielsen, M B & Schmidt, H 2020, ' Severe steroid refractory gastritis induced by Nivolumab : A case report ', Shijie Huaren Xiaohua Zazhi, vol. 26, no. 16, pp. 1971-1978 . https://doi.org/10.3748/wjg.v26.i16.1971Subject Terms: Melanoma/immunology, Skin Neoplasms, Adolescent, Skin Neoplasms/immunology, Drug Resistance, Case Report, Gastritis/diagnosis, Severity of Illness Index, Immune checkpoint inhibitors, 03 medical and health sciences, Chemotherapy, Adjuvant/adverse effects, Glucocorticoids/pharmacology, 0302 clinical medicine, Immune Checkpoint Inhibitors/adverse effects, Immune-related adverse events, Case report, Humans, Glucocorticoids, Immune Checkpoint Inhibitors, Melanoma, Nivolumab/adverse effects, Infliximab, 3. Good health, Infliximab/therapeutic use, Nivolumab, Treatment Outcome, Chemotherapy, Adjuvant, Gastritis, Female
File Description: application/pdf
-
7
Authors: et al.
Source: Archives of Gynecology and Obstetrics. 301:1227-1233
Subject Terms: Ovariectomy / methods, Adult, Fertility-sparing surgery, Adolescent, Croatia, Ovariectomy, Ovarian Neoplasms / pathology, Tertiary Care Centers, Young Adult, Malignant ovarian germ cell tumors, 03 medical and health sciences, 0302 clinical medicine, Pregnancy, Humans, Ovarian Neoplasms / drug therapy, Neoplasm Staging, Retrospective Studies, Ovarian Neoplasms, Reproductive outcome, Teratoma, Teratoma / pathology, Fertility Preservation, Neoplasm Recurrence, Local / pathology, Neoplasms, Germ Cell and Embryonal / pathology, Middle Aged, Neoplasms, Germ Cell and Embryonal, Neoplasms, Germ Cell and Embryonal / drug therapy, Adjuvant chemotherapy, 3. Good health, Omentum / surgery, Fertility, Chemotherapy, Adjuvant, Neoplasms, Germ Cell and Embryonal / surgery, Lymph Node Excision, Ovarian Neoplasms / surgery, Female, Chemotherapy, Adjuvant / adverse effects, Neoplasm Recurrence, Local, Omentum
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/32253553
https://www.bib.irb.hr/1139186
https://doi.org/10.1007/s00404-020-05522-5
https://link.springer.com/article/10.1007/s00404-020-05522-5
https://europepmc.org/article/MED/32253553
https://pubmed.ncbi.nlm.nih.gov/32253553/
https://www.ncbi.nlm.nih.gov/pubmed/32253553
https://urn.nsk.hr/urn:nbn:hr:105:015670
https://doi.org/10.1007/s00404-020-05522-5 -
8
Authors: et al.
Contributors: et al.
Source: International Journal of Cancer, 146, 2, pp. 439-448
Subject Terms: Cancer Research, Indoles, Oncologie, Ovarian Neoplasms/therapy, Carboplatin, Placebos, tyrosine kinase inhibitor, 0302 clinical medicine, Ovarian Neoplasms/pathology, Antineoplastic Combined Chemotherapy Protocols, Paclitaxel/adverse effects, nintedanib, Human health sciences, Medical Oncology - Radboud University Medical Center, Aged, 80 and over, Ovarian Neoplasms, Indoles/administration & dosage, Cytoreduction Surgical Procedures, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, Progression-Free Survival, 3. Good health, ovarian cancer, Oncology, Chemotherapy, Adjuvant, Indoles/adverse effects, Female, Chemotherapy, Adjuvant/methods, Ovarian Neoplasms/mortality, Adult, Paclitaxel, overall survival, Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences, Protein Kinase Inhibitors/adverse effects, Sciences de la santé humaine, Young Adult, 03 medical and health sciences, Carboplatin/adverse effects, Chemotherapy, Adjuvant/adverse effects, Paclitaxel/administration & dosage, Ovary/surgery, Humans, Protein Kinase Inhibitors, Aged, Neoplasm Staging, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Protein Kinase Inhibitors/administration & dosage, Ovary, Carboplatin/administration & dosage, antiangiogenic, anti-angiogenic, Ovary/pathology, Follow-Up Studies
Access URL: https://pubmed.ncbi.nlm.nih.gov/31381147
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/218867
https://doi.org/10.1002/ijc.32606
https://publicatt.unicatt.it/handle/10807/141114
https://boa.unimib.it/handle/10281/241889
https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201902219141510847
https://moh-it.pure.elsevier.com/en/publications/final-results-from-gcigengotago-ovar-12-a-randomised-placebo-cont
https://www.ncbi.nlm.nih.gov/pubmed/31381147
https://europepmc.org/article/MED/31381147
https://hdl.handle.net/2066/218867
https://repository.ubn.ru.nl//bitstream/handle/2066/218867/218867.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.32606
https://doi.org/10.1002/ijc.32606
https://hdl.handle.net/10281/241889
https://hdl.handle.net/2268/309155
https://doi.org/10.1002/ijc.32606
https://hdl.handle.net/10807/141114
https://doi.org/10.1002/ijc.32606 -
9
Authors: et al.
Source: BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)Subject Terms: Adult, Male, Pancreatic surgery, Leucovorin, Adenocarcinoma, Irinotecan, Leucovorin/administration, Liver Neoplasms/surgery [MeSH], Liver Neoplasms/mortality [MeSH], Pancreatic Neoplasms/pathology [MeSH], Liver metastasis, Progression-Free Survival [MeSH], Neoadjuvant Therapy/adverse effects [MeSH], Neoadjuvant Therapy/methods [MeSH], Adenocarcinoma/secondary [MeSH], Male [MeSH], Adenocarcinoma/drug therapy [MeSH], Liposomes [MeSH], Quality of Life [MeSH], Chemotherapy, Adjuvant/methods [MeSH], Pancreatic Neoplasms/mortality [MeSH], Pancreatic Neoplasms/surgery [MeSH], Pancreatic cancer, Fluorouracil/administration, Oxaliplatin/administration, Female [MeSH], Adult [MeSH], Study Protocol, Humans [MeSH], Irinotecan/administration, Pancreatic Neoplasms/drug therapy [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Clinical trials, Liver Neoplasms/secondary [MeSH], Germany [MeSH], Chemotherapy, Chemotherapy, Adjuvant/adverse effects [MeSH], Adenocarcinoma/mortality [MeSH], Adenocarcinoma/surgery [MeSH], 03 medical and health sciences, Clinical Trials, Phase II as Topic, 0302 clinical medicine, Germany, Antineoplastic Combined Chemotherapy Protocols, Humans, Multicenter Studies as Topic, RC254-282, Liver Neoplasms, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Neoadjuvant Therapy, Progression-Free Survival, 3. Good health, Oxaliplatin, Pancreatic Neoplasms, Chemotherapy, Adjuvant, Liposomes, Quality of Life, Female, Fluorouracil
Access URL: https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-021-08966-3
https://pubmed.ncbi.nlm.nih.gov/34794396
https://doaj.org/article/616c088826884c7d99c7984e35c6d4f5
https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-021-08966-3
https://pubmed.ncbi.nlm.nih.gov/34794396/
https://0-bmccancer-biomedcentral-com.brum.beds.ac.uk/track/pdf/10.1186/s12885-021-08966-3
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600696
https://repository.publisso.de/resource/frl:6462401 -
10
Authors: et al.
Source: International Journal of Cancer, 146 (2), 439 - 448 (2020-01-15)
Subject Terms: antiangiogenic, nintedanib, ovarian cancer, overall survival, tyrosine kinase inhibitor, Indoles, Placebos, Protein Kinase Inhibitors, Carboplatin, Paclitaxel, Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Carboplatin/administration & dosage, Carboplatin/adverse effects, Chemotherapy, Adjuvant/adverse effects, Chemotherapy, Adjuvant/methods, Cytoreduction Surgical Procedures, Female, Follow-Up Studies, Humans, Indoles/administration & dosage, Indoles/adverse effects, Middle Aged, Neoplasm Staging, Ovarian Neoplasms/mortality, Ovarian Neoplasms/pathology, Ovarian Neoplasms/therapy, Ovary/pathology, Ovary/surgery, Paclitaxel/administration & dosage, Paclitaxel/adverse effects, Progression-Free Survival, Protein Kinase Inhibitors/administration & dosage, Protein Kinase Inhibitors/adverse effects, Young Adult, Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Adjuvant, Ovarian Neoplasms, Ovary, Oncology, Cancer Research, Human health sciences, Sciences de la santé humaine, Oncologie
Relation: https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32606; urn:issn:0020-7136; urn:issn:1097-0215
Access URL: https://orbi.uliege.be/handle/2268/309155
-
11
Authors: et al.
Contributors: et al.
Source: Pritchard-Jones, K, Bergeron, C, de Camargo, B, van den Heuvel-Eibrink, M M, Acha, T, Godzinski, J, Oldenburger, F, Boccon-Gibod, L, Leuschner, I, Vujanic, G, Sandstedt, B, de Kraker, J, van Tinteren, H, Graf, N & SIOP Renal Tumours Study Group 2015, 'Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001) : an open-label, non-inferiority, randomised controlled trial', Lancet, vol. 386, no. 9999, pp. 1156-1164. https://doi.org/10.1016/S0140-6736(14)62395-3
The Lancet, Vol. 386, No 9999 (2015) pp. 1156-64Subject Terms: Male, Adolescent, Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use, 610 Medicine & health, 2700 General Medicine, Kaplan-Meier Estimate, Nephrectomy, Wilms Tumor, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Child, Kidney Neoplasms/drug therapy/pathology/surgery, Neoplasm Staging, Neoadjuvant Therapy/adverse effects/methods, ddc:618, Infant, Doxorubicin/administration & dosage/adverse effects, Kidney Neoplasms, Neoadjuvant Therapy, 3. Good health, Treatment Outcome, Wilms Tumor/drug therapy/pathology/surgery, 10036 Medical Clinic, Chemotherapy, Adjuvant, Doxorubicin, Vincristine, Child, Preschool, Dactinomycin, Chemotherapy, Adjuvant/adverse effects/methods, Dactinomycin/administration & dosage/adverse effects, Female, Vincristine/administration & dosage/adverse effects
File Description: application/pdf; 1-s2.0-S0140673614623953-main.pdf - application/pdf
Access URL: http://www.thelancet.com/article/S0140673614623953/pdf
https://pubmed.ncbi.nlm.nih.gov/26164096
http://www.uni-saarland.de/fileadmin/user_upload/Fachrichtungen/fr215_Paediatrie/Kliniken/Klinik_fuer_Onkologie_und_haematologie/Publikationen/14TL5273.pdf
http://www.diva-portal.org/smash/record.jsf?pid=diva2:891856
https://archive-ouverte.unige.ch/unige:97169/ATTACHMENT01
https://vbn.aau.dk/da/publications/omission-of-doxorubicin-from-the-treatment-of-stage-iiiii-intermediaterisk-wilms-tumour-siop-wt-2001(037a7ebc-adc6-4834-8182-1e3531fab870).html
https://www.sciencedirect.com/science/article/abs/pii/S0140673614623953#!
https://archive-ouverte.unige.ch/unige:97169
https://archive-ouverte.unige.ch/unige:97169 -
12
Authors:
Source: Hjerteforum. 29(1):132
-
13
Authors: et al.
Contributors: et al.
Subject Terms: Randomized control trial, Male, Adult, Cancer Research, Clinical Trial, Phase III, Colorectal neoplasms, Disease-Free Survival, Clinical Trial, Phase II, Chemotherapy, Adjuvant/adverse effects, Oxaliplatin/administration & dosage, Genetics, Journal Article, Humans, Mortality, Neoplasm Metastasis, Perioperative Period, Bevacizumab/administration & dosage, Peritoneum/drug effects, Progression-free survival, Colorectal Neoplasms/drug therapy, Middle Aged, Peritoneal Neoplasms/drug therapy, Cytoreduction surgical procedures, Combined Modality Therapy, Progression-Free Survival, 3. Good health, Adjuvant chemotherapy, Peritoneal neoplasms, Bevacizumab, Fluorouracil/administration & dosage, Hyperthermia, induced, Oncology, Randomized controlled trial, Cytoreduction Surgical Procedures/adverse effects, Neoadjuvant therapy, Randomized Controlled Trial, Leucovorin/administration & dosage, Quality of Life, Female
File Description: image/pdf
Access URL: https://dspace.library.uu.nl/handle/1874/389526
-
14
Authors: et al.
Source: Nursing Research. 60:256-263
Subject Terms: Quality of life, Questionnaires, Adult, Male, oropharyngeal mucositis, Psychometrics, name=General Nursing, Adjuvant - Adverse Effects, 80 And Over, Head And Neck Neoplasms - Complications - Therapy, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Oropharyngeal mucositis, Models, Surveys and Questionnaires, Radiotherapy, Adjuvant - Adverse Effects, instrument, Chemotherapy, Humans, Stomatitis - Etiology - Psychology, Quality Of Life, Aged, Aged, 80 and over, Stomatitis, Models, Statistical, Radiotherapy, Rasch analysis, Instrument, Statistical, Middle Aged, Aged, 80 And Over, name=SDG 3 - Good Health and Well-being, 3. Good health, Chemotherapy, Adjuvant - Adverse Effects, Psychometrics - Methods, quality of life, Chemotherapy, Adjuvant, Head and Neck Neoplasms, Quality of Life, Female, Radiotherapy, Adjuvant
Access URL: https://pubmed.ncbi.nlm.nih.gov/21691240
http://www.ncbi.nlm.nih.gov/pubmed/21691240
https://dialnet.unirioja.es/servlet/articulo?codigo=3776033
https://europepmc.org/abstract/MED/21691240
https://acuresearchbank.acu.edu.au/item/86wv7/use-of-rasch-analysis-in-the-evaluation-of-the-oropharyngeal-mucositis-quality-of-life-scale
https://mdanderson.elsevierpure.com/en/publications/use-of-rasch-analysis-in-the-evaluation-of-the-oropharyngeal-muco
http://hub.hku.hk/handle/10722/163382
https://acuresearchbank.acu.edu.au/item/86wv7/use-of-rasch-analysis-in-the-evaluation-of-the-oropharyngeal-mucositis-quality-of-life-scale
http://hdl.handle.net/10722/163382 -
15
Authors: et al.
Source: British Journal of Surgery, Vol. 96, No 1 (2009) pp. 95-103
Subject Terms: Adult, Male, Reoperation, ddc:616.07, 616.07, Hepatectomy/*methods/mortality, 03 medical and health sciences, Chemotherapy, Adjuvant/adverse effects, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Hepatectomy, Humans, Colorectal Neoplasms, Antineoplastic Combined Chemotherapy Protocols/*adverse effects, Aged, ddc:616, Postoperative Care, Reoperation/mortality, ddc:617, Postoperative Care/mortality, Portal Vein, Liver Neoplasms, Liver Neoplasms/pathology/secondary/*therapy, Middle Aged, Embolization, Therapeutic, Survival Analysis, 3. Good health, Treatment Outcome, Neoplasm Recurrence, Local/mortality/pathology, Chemotherapy, Adjuvant, Feasibility Studies, Female, Neoplasm Recurrence, Local, Embolization, Therapeutic/methods/mortality
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/19109800
https://core.ac.uk/display/60825396
https://bjssjournals.onlinelibrary.wiley.com/doi/full/10.1002/bjs.6436
http://onlinelibrary.wiley.com/doi/10.1002/bjs.6436/abstract
https://archive-ouverte.unige.ch/unige:19960
https://europepmc.org/article/MED/19109800
https://academic.oup.com/bjs/article/96/1/95/6141990
https://archive-ouverte.unige.ch/unige:19960 -
16
Authors: et al.
Source: Oncology. 77:107-112
Subject Terms: Adult, Neutropenia/epidemiology/*prevention & control, Neutropenia, Dose-Response Relationship, Drug, Fever, Filgrastim, Incidence, Fever/epidemiology/*prevention & control, Breast Neoplasms, Granulocyte Colony-Stimulating Factor/*therapeutic use, Middle Aged, Recombinant Proteins, Polyethylene Glycols, 3. Good health, 03 medical and health sciences, Chemotherapy, Adjuvant/adverse effects, 0302 clinical medicine, Breast Neoplasms/drug therapy, Chemotherapy, Adjuvant, Case-Control Studies, Granulocyte Colony-Stimulating Factor, Humans, Female, Aged
-
17
Authors: et al.
Source: Osteoporosis International. 18:1439-1450
Subject Terms: Adult, Male, Bone loss, Bone Density Conservation Agents/therapeutic use, Antineoplastic Agents, Breast Neoplasms, Sciences de la santé humaine, 03 medical and health sciences, Chemotherapy, Adjuvant/adverse effects, 0302 clinical medicine, Breast Neoplasms/drug therapy, Bisphosphonate, Animals, Humans, Human health sciences, Aged, Bone Density Conservation Agents, Osteoporosis/chemically induced/diagnosis/therapy, Aromatase Inhibitors, Prostatic Neoplasms, Aromatase inhibitor, Antineoplastic Agents/adverse effects, Sciences bio-médicales et agricoles, Middle Aged, 3. Good health, Postmenopause, Adjuvant cancer treatment, Premenopause, Chemotherapy, Adjuvant, Osteoporosis, Prostatic Neoplasms/drug therapy, Female, Aromatase Inhibitors/adverse effects, Androgen deprivation, General & internal medicine, Médecine générale & interne
File Description: No full-text files
Access URL: https://pubmed.ncbi.nlm.nih.gov/17690930
http://dial.uclouvain.be/handle/boreal:37302
https://link.springer.com/article/10.1007/s00198-007-0439-4
https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/83360/Details
https://www.ncbi.nlm.nih.gov/pubmed/17690930
https://biblio.ugent.be/publication/391734
https://orbi.uliege.be/handle/2268/20502
https://hdl.handle.net/2268/20502
https://doi.org/10.1007/s00198-007-0439-4 -
18
Authors: et al.
Source: Larsen, F O, Christiansen, A B, Rishøj, A, Nelausen, K M & Nielsen, D L 2018, ' Safety and feasibility of home-based chemotherapy ', Danish Medical Journal, vol. 65, no. 5, A5482 . < http://ugeskriftet.dk/files/a5482_safety_and_feasibility_of_home-based_chemotherapy.pdf >
Subject Terms: Adult, Male, Organoplatinum Compounds, Ambulatory Care Facilities, 03 medical and health sciences, Chemotherapy, Adjuvant/adverse effects, 0302 clinical medicine, Colonic Neoplasms/drug therapy, 80 and over, Chemotherapy, Humans, Adjuvant/adverse effects, Organoplatinum Compounds/administration & dosage, Capecitabine, Aged, Aged, 80 and over, Cross-Over Studies, Patient Preference, Middle Aged, Home Care Services, 3. Good health, Oxaliplatin, Capecitabine/administration & dosage, Chemotherapy, Adjuvant, Colonic Neoplasms, Linear Models, Quality of Life, Feasibility Studies, Female, Patient Safety
File Description: application/pdf
-
19
Authors: et al.
Source: Ophthalmic Surgery, Lasers and Imaging Retina. 37:82-85
Subject Terms: 0301 basic medicine, Retinal Neoplasms, Antineoplastic Agents, Adjuvant - Adverse Effects, Antineoplastic Agents - Adverse Effects - Therapeutic Use, Retinoblastoma - Pathology - Therapy, Laser Coagulation - Methods, 03 medical and health sciences, 0302 clinical medicine, Cryotherapy - Adverse Effects, Minimally Invasive, Surgical Procedures, Minimally Invasive, Chemotherapy, Humans, Minimally Invasive Surgical Procedures, 10. No inequality, 2. Zero hunger, Surgical Procedures, Laser Coagulation, Scleral Buckling - Methods, Retinal Detachment, Retinoblastoma, Infant, Retinal Detachment - Etiology - Pathology - Surgery, 3. Good health, Chemotherapy, Adjuvant - Adverse Effects, Scleral Buckling, Chemotherapy, Adjuvant, Cryotherapy, Retinal Neoplasms - Pathology - Therapy, Female, Follow-Up Studies
Access URL: https://pubmed.ncbi.nlm.nih.gov/16468560
https://www.healio.com/ophthalmology/journals/osli/2006-1-37-1/{db02a755-e56f-456a-9714-387df1fed170}/minimally-invasive-method-for-repair-of-rhegmatogenous-retinal-detachment-following-treatment-for-retinoblastoma
https://europepmc.org/article/MED/16468560
http://hub.hku.hk/handle/10722/176439
https://www.ncbi.nlm.nih.gov/pubmed/16468560
http://hdl.handle.net/10722/176439 -
20
Authors: et al.
Source: The Breast Journal. 9:241-245
Subject Terms: Adult, Breast Neoplasms/*drug therapy/surgery, Epirubicin/administration & dosage, Breast Neoplasms, Cyclophosphamide/administration & dosage, Diagnosis, Differential, 03 medical and health sciences, Chemotherapy, Adjuvant/adverse effects, Fatal Outcome, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Granulocyte Colony-Stimulating Factor, Humans, Antineoplastic Combined Chemotherapy Protocols/*adverse effects, Leukemia, Myeloid, Acute/chemically induced/*diagnosis, Methotrexate/administration & dosage, Cyclophosphamide, Granulocyte Colony-Stimulating Factor/administration & dosage, Epirubicin, Carcinoma, Ductal, Breast, 3. Good health, Carcinoma, Ductal, Breast/drug therapy/surgery, Carcinoma, Lobular, Leukemia, Myeloid, Acute, Fluorouracil/administration & dosage, Methotrexate, Chemotherapy, Adjuvant, Female, Fluorouracil, Carcinoma, Lobular/drug therapy/surgery
Full Text Finder 
Nájsť tento článok vo Web of Science 
Full Text